Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity
4CMenB is an approved multi-component vaccine against Serogroup B meningococcus. Here the authors develop a protein microarray for three major 4CMenB antigenic components (fHbp, NHBA and NadA) and describe antibody repertoires in sera from vaccinated infants, adolescents and adults correlating with...
Guardado en:
Autores principales: | E. Bartolini, E. Borgogni, M. Bruttini, A. Muzzi, M. Giuliani, S. Iozzi, R. Petracca, M. Martinelli, S. Bonacci, S. Marchi, C. Brettoni, C. Donati, G. Torricelli, S. Guidotti, M. Domina, C. Beninati, G. Teti, F. Felici, R. Rappuoli, F. Castellino, G. Del Giudice, V. Masignani, M. Pizza, D. Maione |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d17db449f7f4c719c7020da2ad12e49 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland
por: Margherita Bodini, et al.
Publicado: (2020) -
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Isolated from 2009 to 2013 in the Republic of Ireland
por: Robert M. Mulhall, et al.
Publicado: (2018) -
Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Strains and Their Predicted Coverage by the 4CMenB Vaccine
por: Raymond S. W. Tsang, et al.
Publicado: (2020) -
Immunosignaturing can detect products from molecular markers in brain cancer.
por: Alexa K Hughes, et al.
Publicado: (2012) -
METHOD OF IMMUNOSIGNATURE IN DIFFERENTIAL DIAGNOSIS OF AUTISM SPECTRUM DISORDERS. A PILOT STUDY
por: Yu. Yu. Filippova, et al.
Publicado: (2019)